It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?
For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...
Journavx can be taken with ibuprofen for its anti-inflammatory effects. The prescription medication is not in pharmacies yet, but it maybe there by the end of February. Click here to report a typo.
For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
This month the FDA has approved Journavx, a medication that mimics proteins that can help block pain signals from reaching ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
In World War II, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...
Vertex sees 2025 revenue of $11.75 billion to $12.0 billion, the midpoint of which is above analysts' average expectation of ...
To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results